Cell-based assay for anti-AQP4 antibody in Korean patients with neuromyelitis optica

Cell-based assay for anti-AQP4 antibody in Korean patients with neuromyelitis optica

Dettagli Bibliografici
Autori principali:	Kim, B, Han, S, Kang, E, Kim, M, Min, J, Vincent, A, Waters, P, Lee, K
Natura:	Conference item
Pubblicazione:	2010

Documenti analoghi

Anti-aquaporin 4 antibody-positivity of Korean patients with neuromyelitis optica spectrum disorders
di: Min, J, et al.
Pubblicazione: (2010)

Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays.
di: Waters, P, et al.
Pubblicazione: (2008)

AQP4ex is crucial for the anchoring of AQP4 at the astrocyte end-feet and for neuromyelitis optica antibody binding
di: Claudia Palazzo, et al.
Pubblicazione: (2019-04-01)

Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.
di: Kim, S, et al.
Pubblicazione: (2013)

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
di: Waters, P, et al.
Pubblicazione: (2016)

No association of AQP4 polymorphisms with neuromyelitis optica and multiple sclerosis
di: Yang Ting-Ting, et al.
Pubblicazione: (2016-01-01)

Features of the diagnosis and treatment of patients with AQP-4-positive neuromyelitis optica and MOG antibody disease
di: V. E. Avdeeva, et al.
Pubblicazione: (2021-11-01)

Effects of early intervention in neuromyelitis optica spectrum disorder patients with seropositive AQP4 antibodies
di: Binbin Xue, et al.
Pubblicazione: (2024-11-01)

Serum antinuclear antibodies associate with worse prognosis in AQP4‐positive neuromyelitis optica spectrum disorder
di: Rong Fan, et al.
Pubblicazione: (2021-01-01)

Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
di: Jarius, S, et al.
Pubblicazione: (2008)

MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis
di: Laura Clarke, et al.
Pubblicazione: (2021-09-01)

Neuromyelitis Optica with NMO-IgG/ Anti-AQP4 Antibody Positive: First Case Reported from Uttarakhand India
di: Manish Mittal, et al.
Pubblicazione: (2014-07-01)

Characterizing mortality in patients with AQP4‐Ab + neuromyelitis optica spectrum disorder
di: Francis, A, et al.
Pubblicazione: (2024)

Characterizing mortality in patients with AQP4‐Ab+ neuromyelitis optica spectrum disorder
di: Anna Francis, et al.
Pubblicazione: (2024-07-01)

Neuromyelitis optic with positive Anti-AQP4 and Anti-SSA/Ro antibody
di: Riwanti Estiasari, et al.
Pubblicazione: (2019-03-01)

Novel Anti-Neuronal Antibodies in Neuromyelitis Optica Patients with or without Aquaporin-4 Antibodies
di: Cavus, F, et al.
Pubblicazione: (2013)

Correlation between serum AQP-4 antibody, inflammatory cytokines and recurrence of neuromyelitis optica in patients with chronic insomnia
di: WANG Feng, et al.
Pubblicazione: (2022-12-01)

Neuromyelitis optica in patients with gluten sensitivity associated with antibodies to aquaporin-4.
di: Jarius, S, et al.
Pubblicazione: (2008)

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica
di: Jarius, S, et al.
Pubblicazione: (2008)

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.
di: Jarius, S, et al.
Pubblicazione: (2008)

THE ASSOCIATION OF TWO RARE NEUROLOGICAL DISEASES: A MULTICENTRE STUDY OF 16 PATIENTS WITH ACHR ANTIBODY MYASTHENIA GRAVIS AND AQP4 ANTIBODY NEUROMYELITIS OPTICA SPECTRUM DISORDER
di: Leite, M, et al.
Pubblicazione: (2012)

Frequency of Aqp4-Ab in patients with neuromyelitis optica (Devic's syndrome) is higher than predicted by NMO-IgG testing
di: Jarius, S, et al.
Pubblicazione: (2007)

Meningitis as a recurrent manifestation of anti-AQP4/anti-MOG negative neuromyelitis optica spectrum disorder: a case report
di: Chenyang Zhang, et al.
Pubblicazione: (2021-03-01)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
di: Waters, P, et al.
Pubblicazione: (2015)

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
di: Paul, F, et al.
Pubblicazione: (2007)

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
di: Friedemann Paul, et al.
Pubblicazione: (2007-04-01)

Symptomatic brain involvement as the initial manifestation of neuromyelitis optica.
di: Min, J, et al.
Pubblicazione: (2013)

Neuromyelitis optica spectrum disorders associated with AQP4-positive-cancer—A case series
di: Yinghui Duan, et al.
Pubblicazione: (2022-12-01)

Mirror-Image Lesions in Sequential Relapses of AQP4-Positive Neuromyelitis Optica Spectrum Disorder
di: Ryan T. Muir, et al.
Pubblicazione: (2020-05-01)

Complement-dependent bystander injury to neurons in AQP4-IgG seropositive neuromyelitis optica
di: Tianjiao Duan, et al.
Pubblicazione: (2018-10-01)

Anti-MOG Antibodies in Japanese Patients with Neuromyelitis Optica Spectrum Disorders
di: Sato, D, et al.
Pubblicazione: (2014)

Satralizumab as an add-on treatment in refractory pediatric AQP4-antibody-positive neuromyelitis optica spectrum disorder: a case report
di: Xiaojing Li, et al.
Pubblicazione: (2023-10-01)

Complement-independent bystander injury in AQP4-IgG seropositive neuromyelitis optica produced by antibody-dependent cellular cytotoxicity
di: Tianjiao Duan, et al.
Pubblicazione: (2019-07-01)

Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients.
di: Akman-Demir, G, et al.
Pubblicazione: (2011)

Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis.
di: Waters, P, et al.
Pubblicazione: (2008)

NEUROMYELITIS OPTICA SPECTRUM AND RELATIONSHIP WITH AQUAPORIN-4 ANTIBODY DISEASE: THE OXFORD COHORT
di: Leite, M, et al.
Pubblicazione: (2009)

Anti-aquaporin-4 antibodies in Devic’s neuromyelitis optica: therapeutic implications
di: Romain Marignier, et al.
Pubblicazione: (2010-09-01)

A rare case of systemic lupus erythematosus‐associated neuromyelitis optica spectrum disorder with cystic lesions and dual seropositivity for anti‐AQP4 and anti‐MOG antibodies
di: Omar Al Jassem, et al.
Pubblicazione: (2024-09-01)

The Importance of Aquaporin-4 Antibody Assays in Patients beyond the Diagnostic Criteria for Neuromyelitis Optica Spectrum Disorders
di: Sato, D, et al.
Pubblicazione: (2013)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
di: Kitley, J, et al.
Pubblicazione: (2013)